Accessibility Statement Skip Navigation
  • Resources
  • Data Privacy
  • Contact Us
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • All Multimedia

        • All Multimedia
        • All Photos
        • All Videos
    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Accessories
        • Computer Hardware
        • Computer Networks
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High-Tech Security
        • Internet Technology
        • Nanotechnology
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art, Culture & Design
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Projections or Forecasts
        • Financing Agreements
        • Insurance
        • Joint Ventures
        • Mutual Funds
        • Offerings
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing/marketing agreements
        • New Products & Services
        • Obituary
        • Outsourcing Businesses
        • Overseas Real Estate (Non-US)
        • Personnel Announcements
        • Residential Real Estate
        • Small-Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Accessories
        • Computer Electronics
        • Computer Hardware
        • Computer Networks
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Design Automation
        • Financial Technology
        • Mobile Devices/Apps
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Natural Gas Utilities
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Computer Accessories
        • Computer Networks
        • Mobile Devices/Apps
        • Telecommunications
        • Telecommunications Carriers & Services
        • Telecommunications Equipment
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wine & Spirits
        • Beverages
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art, Culture & Design
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infectious Disease Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental Products & Services
        • European Government
        • Natural Disasters
        • Not-for-Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Children-related news
        • Disabled Persons
        • Diversity, Equity & Inclusion
        • Hispanic-oriented news
        • LGBTQ+
        • Religion
        • Senior Citizens
        • Veterans
        • Women-Related news
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Request a Demo
    • Partnerships
    • Media Inquiries
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring Home
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us


    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • News Releases
      • Send a Release
      • Data Privacy
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • News Releases
      • Send a Release
      • Data Privacy
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • News Releases
      • Send a Release
      • Data Privacy
      • General Inquiries
      • Request a Demo
      • Partnerships
      • Media Inquiries
      • Editorial Bureaus
      • News Releases
      • Send a Release
      • Data Privacy
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • All Multimedia
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      From Asia to the Global Oncology Stage: Gene Solutions Contributes Multi-Omic Innovation at ESMO Congress 2026


      News provided by

      GENE SOLUTIONS SGP PTE. LTD.

      18 Nov, 2026, 06:00 CST

      Share this article

      Share this article


      MADRID, Nov. 18, 2026 /PRNewswire/ -- Gene Solutions hosted its first Global Industry Satellite Symposium, sharing multi-omic liquid biopsy technologies and the clinical and real-world data generated in Asia with the international oncology community. The achievement reflects the company's evolution from an Asia-based genetic testing pioneer to a globally engaged innovator of cell-free DNA technologies spanning cancer screening, precision oncology, and functional applications.

      Continue Reading
      From Asia to the Global Oncology Stage: Gene Solutions Contributes Multi-Omic Innovation at ESMO Congress 2026
      From Asia to the Global Oncology Stage: Gene Solutions Contributes Multi-Omic Innovation at ESMO Congress 2026
      A patient-centered precision oncology ecosystem integrating earlier detection, genomic profiling, multi-omic and immune insights, functional testing, and ctDNA monitoring.
      A patient-centered precision oncology ecosystem integrating earlier detection, genomic profiling, multi-omic and immune insights, functional testing, and ctDNA monitoring.

      ESMO Congress, one of the world's leading oncology meetings, brought together more than 40,000 participants from the global cancer community in Madrid in 2026 for the largest congress in ESMO's history. The meeting provided a platform for scientific exchange on advances in precision oncology.

      The symposium, titled "AI-Enabled Multi-omic Liquid Biopsy Across the Cancer Care Continuum: From Technological Innovation to Scalable Clinical Implementation," was attended at full capacity and convened internationally recognized experts, including Prof. Umberto Malapelle, President of the International Society of Liquid Biopsy and Professor at the University of Naples Federico II; Prof. Herbert Ho Fung Loong of The Chinese University of Hong Kong; Prof. Aya El Helali of The University of Hong Kong; Dr. Le Son Tran and Dr. Vien Le of the Medical Genetics Institute; and Asst. Prof. Lucksamon Thamlikitkul of Siriraj Hospital, Mahidol University.  

      The program reviewed multi-omic technologies and evidence from Asia, encompassing both prospective clinical studies and real-world datasets. Sessions focused on challenges and future directions in multi-cancer early detection, comprehensive genomic and transcriptomic profiling, longitudinal ctDNA monitoring, and immune profiling as well as functional patient-derived organoid models for evaluating treatment response to support therapeutic decision-making.

      Discussions across the presentations highlighted the value of integrating complementary multi-omic approaches rather than relying on any single technology. Drawing on clinical validation and real-world experience generated in Asia, Gene Solutions' patient-centered ecosystem was highlighted, connecting earlier detection, comprehensive genomic profiling, deeper biological and immune understanding, functional investigation of treatment response, and longitudinal circulating tumor DNA monitoring around the needs of the same patient. The approach is intended to support more individualized care while addressing the practical requirements of implementation across diverse healthcare settings.

      Reflecting on the symposium discussions, Prof. Umberto Malapelle, President of the International Society of Liquid Biopsy, emphasized the growing significance of multi-cancer early detection:

      "We discussed how the cancer-screening landscape is evolving and the potential role of multi-cancer early detection. MCED assays represent one of the key weapons in this battle against cancer. The technology is now available, promising data are emerging from different settings, and the next step is to generate the prospective evidence needed to demonstrate clinical utility and support appropriate implementation."

      Beyond early detection, symposium discussions also addressed how advanced molecular technologies can be translated into routine cancer care across diverse healthcare systems.

      As Prof. Herbert Ho Fung Loong of The Chinese University of Hong Kong commented:

      "Liquid biopsy can extend access to accurate genomic profiling in settings where access to tissue-based testing may be limited. Combining liquid and tissue approaches improves the completeness of molecular information available for monitoring, diagnosis, and treatment selection, while generating data that may be relevant beyond the Asian region."

      The symposium also highlighted how precision oncology is evolving beyond genomic alterations alone toward a more comprehensive understanding of disease biology.

      Prof. Aya El Helali of The University of Hong Kong said:

      "Precision oncology increasingly requires a multilayered understanding of disease, integrating genomic, transcriptomic, epigenetic, proteomic, and immune-related information. Bringing these insights together with functional models such as patient-derived organoids may help prioritize more individualized and evidence-driven treatment strategies."

      Gene Solutions and the Medical Genetics Institute also contributed two posters presenting real-world research from Southeast Asia on tissue and liquid-biopsy molecular profiling and longitudinal ctDNA monitoring across multiple cancer types.

      Beyond the scientific program, the company's exhibition area facilitated discussions with oncologists, molecular pathologists, translational researchers, laboratory leaders, healthcare institutions, pharma and industry colleagues throughout the conference.

      Commenting on Gene Solutions' participation at ESMO Congress 2026, Ida Deleskog Lindstroem, Global Medical Affairs Director at Gene Solutions, said:

      "The discussions underscored both the progress made in applying multi-omic liquid biopsy approaches in clinical practice and the remaining challenges in supporting broader access. Our focus remains on advancing technologies that can deliver clinically useful information — from earlier detection to treatment selection and disease monitoring — across different healthcare settings."

      For Gene Solutions, ESMO Congress 2026 represented more than a successful scientific event. It marked an important step in a journey that began in Asia and continues to grow through a commitment to innovations that support earlier cancer detection, more precise treatment decisions, deeper biological understanding, and more effective disease monitoring for patients worldwide.

      Watch the faculty presentations and interviews, view the panel discussion, and explore Gene Solutions' scientific posters at: https://www.genesolutions.com/inside-gene-solutions-esmo-2026-symposium-and-scientific-program-six-perspectives-across-the-cancer-care-continuum/

      About Gene Solutions

      Gene Solutions is a global biotechnology company advancing precision cell-free DNA solutions across cancer detection (SPOT-MAS), precision oncology (K-TRACK, K-4CARE), and pregnancy care (triSure). By combining multi-omic science, data intelligence and a scalable technology platform, Gene Solutions brings world-class genomics closer to clinicians and patients, expanding access to clinically meaningful innovation around the world.

      SOURCE GENE SOLUTIONS SGP PTE. LTD.

      Modal title

      Also from this source

      Gene Solutions Study Finds Preterm-Birth Signals in Routine triSure NIPT Data

      Gene Solutions Study Finds Preterm-Birth Signals in Routine triSure NIPT Data

      Gene Solutions, a global biotechnology company providing precision cell-free DNA solutions through multi-omics and artificial intelligence to improve ...

      Gene Solutions Showcases Global Evidence and Responsible Innovation in Prenatal and Women's Genomic Health at ISPD 2026

      Gene Solutions Showcases Global Evidence and Responsible Innovation in Prenatal and Women's Genomic Health at ISPD 2026

      Gene Solutions, a global biotechnology company focused on accessible and responsible genomics, participated as a Premier Partner at the 30th...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Biotechnology

      Biotechnology

      Clinical Trials & Medical Discoveries

      Clinical Trials & Medical Discoveries

      News Releases in Similar Topics

      Contact PR Newswire

      • General Inquiries
      • Request a Demo
      • Partnerships
      • Media Inquiries

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Become a Publishing Partner
      • Careers
      • Accessibility Statement
      • APAC – Simplified Chinese
      • APAC
      • APAC - Traditional Chinese
      • Arabic
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • United States
      • Vietnam

      My Services

      • All New Releases
      • Platform

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact Cision

      Products

      About

      My Services
      • All News Releases
      • Platform
      [email protected]
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      • Accessibility
      Copyright © 2026 Cision US Inc.